Porous PCL/Chitosan and nHA/PCL/Chitosan scaffolds for tissue engineering applications: fabrication and evaluation

Two semicrystalline polymers were blended to fabricate porous scaffolds for tissue engineering applications. Scaffolds containing polycaprolactone (PCL)/chitosan and nanohydroxyapatite (nHA) incorporated nHA/PCL/chitosan were produced using the freeze-drying technique. A model drug, tetracycline hydrochloride (tetracycline HCL), was incorporated into the scaffolds. The scaffolds were characterized using a scanning electron microscope (SEM), EDX, and water contact angle. The antibacterial properties of the nHA/PCL/chitosan/tetracycline HCL scaffold were tested and the scaffolds showed positive results on gram-positive and gram-negative bacteria. The cell biocompatibility using human skin fibroblast cells (HSF 1184) was examined. The scaffold materials were found to be nontoxic to human skin fibroblast cells (HSF 1184) and showed positive proliferation activities. The nHA/PCL/chitosan/tetracycline HCL scaffold has potential for controlling implant-associated bacterial infections during operative procedures and can potentially be used as a scaffold for tissue engineering applications.

[1]  D. Hutmacher,et al.  The return of a forgotten polymer : Polycaprolactone in the 21st century , 2009 .

[2]  L. Golub,et al.  Using tetracyclines to treat osteoporotic/osteopenic bone loss: from the basic science laboratory to the clinic. , 2011, Pharmacological research.

[3]  Cuie Wen,et al.  Bioactive Materials , 2017 .

[4]  R. Sinisterra,et al.  Bioactive glass as a drug delivery system of tetracycline and tetracycline associated with beta-cyclodextrin. , 2004, Biomaterials.

[5]  N. Sultana,et al.  Factorial study of compressive mechanical properties and primary In Vitro osteoblast response of PHBV/PLLA scaffolds , 2012 .

[6]  Lorenzo Moroni,et al.  Chitosan/poly(epsilon-caprolactone) blend scaffolds for cartilage repair. , 2011, Biomaterials.

[7]  M. Avena,et al.  Antimicrobial properties of tetracycline and minocycline-montmorillonites , 2010 .

[8]  S. Nair,et al.  Novel chitin and chitosan nanofibers in biomedical applications. , 2010, Biotechnology advances.

[9]  Xiaoying Cao,et al.  Compressive mechanical properties and biodegradability of porous poly(caprolactone)/chitosan scaffolds , 2008 .

[10]  N. Selvamurugan,et al.  Preparation, characterization and antimicrobial activity of a bio-composite scaffold containing chitosan/nano-hydroxyapatite/nano-silver for bone tissue engineering. , 2011, International journal of biological macromolecules.

[11]  N. Sultana,et al.  Fabrication and in vitro evaluation of nanosized hydroxyapatite/chitosan-based tissue engineering scaffolds , 2014 .

[12]  Francesca Ungaro,et al.  Controlled drug delivery in tissue engineering. , 2008, Advanced drug delivery reviews.

[13]  Min Wang,et al.  Synthesis of carbonated hydroxyapatite nanospheres through nanoemulsion , 2008, Journal of materials science. Materials in medicine.

[14]  F Franks,et al.  Freeze-drying of bioproducts: putting principles into practice. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[15]  Ming Kong,et al.  Antimicrobial properties of chitosan and mode of action: a state of the art review. , 2010, International journal of food microbiology.

[16]  Nazma N. Inamdar,et al.  Chitosan-modifications and applications: Opportunities galore , 2008 .

[17]  S. Lanceros‐Méndez,et al.  Electrospun silk-elastin-like fibre mats for tissue engineering applications , 2013, Biomedical materials.

[18]  Bin Duan,et al.  Encapsulation and release of biomolecules from Ca-P/PHBV nanocomposite microspheres and three-dimensional scaffolds fabricated by selective laser sintering , 2010 .

[19]  J. Mano,et al.  New poly(epsilon-caprolactone)/chitosan blend fibers for tissue engineering applications. , 2010, Acta biomaterialia.

[20]  R. Fleischmajer,et al.  Tetracyclines: nonantibiotic properties and their clinical implications. , 2006, Journal of the American Academy of Dermatology.

[21]  M. Mohammadi,et al.  In vitro study of hydroxyapatite/polycaprolactone (HA/PCL) nanocomposite synthesized by an in situ sol-gel process. , 2013, Materials science & engineering. C, Materials for biological applications.

[22]  E. Fortunati,et al.  Biodegradable polymer matrix nanocomposites for tissue engineering: A review , 2010 .